Abstract
Despite advances in prevention of cervical cancer in the US, women of Hispanic origin still bear an unequal burden in cervical cancer incidence, morbidity and mortality. Our objective was to determine the HPV vaccine knowledge and acceptability in a group of mostly Hispanic females. In this cross sectional survey, 62 % of participants heard of HPV; 34.9 % identified HPV as a cause of cervical cancer. 63 % of participants reported willingness to receive vaccine and 77 % were willing to vaccinate daughters. Those with previous abnormal PAPs were more likely to have heard of HPV and Vaccine. No other factors examined showed association with willingness to get vaccine or administer to daughters. Knowledge level remains low in this high risk population. Willingness to receive vaccine is high despite lack of access to care. Increased targeted community based education and vaccination programs may be useful in closing disparity in cervical cancer morbidity.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Weinstock H, Berman S, Cates W. Sexually transmitted diseases among American youth: incidence and prevalence estimates. Perspect Sex Reprod Health. 2000;36(1):6–10.
Kahn JA, Hillard PA. Human papillomavirus and cervical cytology in adolescents. Adolesc Med Clin. 2004;15(2):301–321, ix.
Muñoz N, Bosch FX, de Sanjosé S, et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med. 2003;348(6):518–27.
Greer CE, Wheeler CM, Ladner MB, et al. Human papillomavirus (HPV) type distribution and serological response to HPV type 6 virus-like particles in patients with genital warts. J Clin Microbiol. 1995;33(8):2058–63.
WHO/ICO Information Center on HPV and Cervical Cancer (HPV Information Center). Human papillomavirus and related cancers in the world. Summary Report 2010. www.who.int/hpvcentre. Accessed 11 Oct 2012.
Howlander N, Noone AM, Krapcho M, Neyman N, et al. SEER Cancer Statistics Review: National Cancer Institute; 1975–2008. Bethesda, MD: National Cancer Institute. http://seer.cancer.gov/csr/1975_2008. Accessed 11 Oct 2012.
Siegel R, Ward E, Brawley O, Jemal A. Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin. 2011;61(4):212–36.
Risser DR, Mokry B, Bowcock C, Miller EA, Williams MA, Magid R, Garcia R. Cervical Cancer in Texas, 2010. Austin, TX: Texas Cancer Registry, Texas Department of State Health Services; Cancer Prevention Research Institute of Texas; 2010.
de Sanjose S, Quint WG, Alemany L, et al. Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study. Lancet Oncol. 2010;11(11):1048–56.
Szarewski A, Poppe WA, Skinner SR, et al. Efficacy of the human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine in women aged 15–25 years with and without serological evidence of previous exposure to HPV-16/18. Int J Cancer. 2012;131(1):106–16.
Lu B, Kumar A, Castellsagué X, Giuliano AR. Efficacy and safety of prophylactic vaccines against cervical HPV infection and diseases among women: a systematic review & meta-analysis. BMC Infect Dis. 2011;11:13.
Paavonen J, Jenkins D, Bosch FX, et al. Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women: an interim analysis of a phase III double-blind, randomised controlled trial. Lancet. 2007;369(9580):2161–70.
Gottlieb SL, Brewer NT, Sternberg MR, et al. Human papillomavirus vaccine initiation in an area with elevated rates of cervical cancer. J Adolesc Health. 2009;45(5):430–7.
Shen-Gunther J, Shank J, Ta V. Gardasil™ HPV vaccination HPV vaccination: surveillance of vaccine usage and adherence in a military population. Gynecol Oncol. 2011;123:272.
Manhart LE, Burgess-Hull AJ, Fleming CB, Bailey JA, Haggerty KP, Catalano RF. HPV vaccination among a community sample of young adult women. Vaccine. 2011;29(32):5238–44.
(CDC) CfDCaP. National and state vaccination coverage among adolescents aged 13 through 17 years–United States, 2010. MMWR Morb Mortal Wkly Rep. 2011;60(33):1117–23.
Dempsey AF, Zimet GD, Davis RL, Koutsky L. Factors that are associated with parental acceptance of human papillomavirus vaccines: a randomized intervention study of written information about HPV. Pediatrics. 2006;117(5):1486–93.
Davis K, Dickman ED, Ferris D, Dias JK. Human papillomavirus vaccine acceptability among parents of 10- to 15-year-old adolescents. J Low Genit Tract Dis. 2004;8(3):188–94.
Gerend MA, Lee SC, Shepherd JE. Predictors of human papillomavirus vaccination acceptability among underserved women. Sex Transm Dis. 2007;34(7):468–71.
Mays RM, Sturm LA, Zimet GD. Parental perspectives on vaccinating children against sexually transmitted infections. Soc Sci Med. 2004;58(7):1405–13.
Geographic Identifiers: 2010 Demographic Profile Data (G001): Socorro city, Texas. U.S. Census Bureau, American Factfinder. Retrieved 25 Jan 2013 from http://factfinder2.census.gov/faces/nav/jsf/pages/community_facts.xhtml.
Kobetz E, Kornfeld J, Vanderpool RC, Finney Rutten LJ, Parekh N, O’Bryan G, et al. Knowledge of HPV among United States Hispanic women: opportunities and challenges for cancer prevention. J Health Commun. 2010;15(Suppl 3):22–9.
Constantine NA, Jerman P. Acceptance of human papillomavirus vaccination among Californian parents of daughters: a representative statewide analysis. J Adolesc Health. 2007;40(2):108–15.
Kahn JA, Ding L, Huang B, Zimet GD, Rosenthal SL, Frazier AL. Mothers’ intention for their daughters and themselves to receive the human papillomavirus vaccine: a national study of nurses. Pediatrics. 2009;123(6):1439–45.
Sanderson M, Coker AL, Eggleston KS, Fernandez ME, Arrastia CD, Fadden MK. HPV vaccine acceptance among Latina mothers by HPV status. J Womens Health (Larchmt). 2009;18(11):1793–9.
Waller PR, Crow C, Sands D, Becker H. Health related attitudes and health promoting behaviors: differences between health fair attenders and a community group. Am J Health Promot. 1988;3(1):17–23, 32.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Molokwu, J., Fernandez, N.P. & Martin, C. HPV Awareness and Vaccine Acceptability in Hispanic Women Living Along the US-Mexico Border. J Immigrant Minority Health 16, 540–545 (2014). https://doi.org/10.1007/s10903-013-9855-z
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10903-013-9855-z